Singleton; Patrick A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Singleton; Patrick A..The latest application filed is for "use of opioid antagonists".

Company Profile

1.13.17

Singleton; Patrick A. - Chicago IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Opioid Antagonists App 20210145825 - Moss; Jonathan ; et al.	2021-05-20
Treatment with opioid antagonists and mTOR inhibitors Grant 10,383,869 - Moss , et al. A	2019-08-20
Use Of Opioid Antagonists App 20180008594 - Moss; Jonathan ; et al.	2018-01-11
Use Of Opioid Antagonists To Attenuate Endothelial Cell Proliferation And Migration App 20170258909 - Moss; Jonathan ; et al.	2017-09-14
Use Of Opioid Antagonists To Attenuate Endothelial Cell Proliferation And Migration App 20170252336 - Moss; Jonathan ; et al.	2017-09-07
Use of opioid antagonists Grant 9,717,725 - Moss , et al. August 1, 2	2017-08-01
Use of opioid antagonists to attenuate endothelial cell proliferation and migration Grant 9,675,602 - Moss , et al. June 13, 2	2017-06-13
Use of opioid antagonists to attenuate endothelial cell proliferation and migration Grant 9,662,390 - Moss , et al. May 30, 2	2017-05-30
Use of opioid antagonists to attenuate endothelial cell proliferation and migration Grant 9,662,325 - Moss , et al. May 30, 2	2017-05-30
TREATMENT WITH OPIOID ANTAGONISTS AND mTOR INHIBITORS App 20170065581 - Moss; Jonathan ; et al.	2017-03-09
Treatment with opioid antagonists and mTOR inhibitors Grant 9,526,723 - Moss , et al. December 27, 2	2016-12-27
Use Of Opioid Antagonists To Attenuate Endothelial Cell Proliferation And Migration App 20140323426 - Moss; Jonathan ; et al.	2014-10-30
Treatment With Opioid Antagonists And Mtor Inhibitors App 20140163059 - Moss; Jonathan ; et al.	2014-06-12
Modulation Of Cell Barrier Dysfunction App 20140142133 - Alverdy; John C. ; et al.	2014-05-22
Treatment with opioid antagonists and mTOR inhibitors Grant 8,685,995 - Moss , et al. April 1, 2	2014-04-01
Use Of Opioid Antagonists To Attenuate Endothelial Cell Proliferation And Migration App 20140066467 - Moss; Jonathan ; et al.	2014-03-06
Use Of Opioid Antagonists App 20140011831 - Moss; Jonathan ; et al.	2014-01-09
Use of opioid antagonists to attenuate endothelial cell proliferation and migration Grant 8,524,731 - Moss , et al. September 3, 2	2013-09-03
Use of opioid antagonists Grant 8,518,962 - Moss , et al. August 27, 2	2013-08-27
Modulation of Cell Barrier Dysfunction App 20120316190 - Alverdy; John C. ; et al.	2012-12-13
TREATMENT WITH OPIOID ANTAGONISTS AND mTOR INHIBITORS App 20110021551 - Moss; Jonathan ; et al.	2011-01-27
Use Of Opioid Antagonists App 20100286059 - Moss; Jonathan ; et al.	2010-11-11
Methods And Compositions For Treating Diseases And Conditions Involving Higher Molecular Weight Hyaluronan App 20100249064 - Singleton; Patrick A. ; et al.	2010-09-30
Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration App 20080274119 - Moss; Jonathan ; et al.	2008-11-06
Modulation of Cell Barrier Dysfunction App 20080194611 - Alverdy; John C. ; et al.	2008-08-14
Use Of Opioid Antagonists To Attenuate Endothelial Cell Proliferation And Migration App 20060258696 - Moss; Jonathan ; et al.	2006-11-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.